Watch CBS News

Another eye drop recall pulls 28 products off of CVS, Rite Aid, Target and Walmart shelves after FDA warning

FDA warns against using 26 eye drop products due to infection risk
FDA warns against using 26 eye drop products due to infection risk 00:33

Another eye drop recall is pulling 28 products from store shelves, including store-brand products sold at retailers such as CVS, Rite Aid, Target and Walmart, with the recall coming about three weeks after the U.S. Food and Drug Administration warned people not to buy or use the eye drops.

Kilitch Healthcare India is recalling eye drops with expiration dates ranging from November 2023 to September 2025, citing "safety concerns" due to FDA investigators finding unsanitary conditions at the facility where the products were made, according to a news release posted Wednesday by the agency. You can see the full list of recalled eye drops here.

The recall is one of eight separate announcements related to eye drops this year, involving dozens of different brands sold nationwide.

In Kilitch's case, the FDA in late October urged consumers to stop using the manufacturer's products, citing a "risk of eye infections that could result in partial vision loss or blindness." The agency said its investigators found unsanitary conditions and "positive bacterial test results" from areas of an unidentified manufacturing facility. As of Nov. 13, Kilitch said it hasn't received any reports of adverse health effects linked to the recall.

Some of the eye drops may have already been removed from stores, as earlier this month the FDA said CVS, Rite Aid and Target were taking the products off their shelves and websites. 

The recall notice said that distributors and retailers that have any of the recalled products should stop distributing them. Consumers, meanwhile, should stop using the recalled eye drops and return the products to where they purchased them, the FDA said.

Unsanitary conditions

Bloomberg News reported that Kilitch produced the eye drops in an unsanitary factory in India where some workers went barefoot and others made up test results that purported to show the products were sterile. 

The FDA's warning prompted Cardinal Health in early November to recall six Leader brand eye products, while Harvard Drug Group recalled Rugby Laboratories brand eye drops. 

The FDA earlier this year announced a spate of recalls of eye drop products linked to four deaths and multiple cases of vision loss. In August, it warned against using two additional eye drop products because of the risk of bacterial or fungal contamination. 

Eye drop products, which must be sterile in order to be safe, require "much finer oversight on the manufacturing side in order to ensure that there's no contamination whatsoever," Carri Chan, a business professor at Columbia University, told CBS MoneyWatch last week in reference to the spate of recalls.  

Good Question: What guidelines should we follow when buying eye drops? 02:25

The FDA keeps an updated list of eye drop products that consumers should discard. Users can also consult an eye drop manufacturer's website to check if a product has been recalled. 

Dr. Christopher Starr, a spokesman for the American Academy of Ophthalmology, said people should seek medical help immediately if they experience adverse reactions to their eye drops, told CBS MoneyWatch. Signs of an infection typically include discharge, redness or pain. Consumers should also check a product's expiration date before use.

Consumers with questions about the recall can contact Kilitch at or Velocity Pharma, Kilitch's distributor, at Eye drop users who experience adverse reactions can file a report with the FDA online or by downloading and mailing a pre-addressed form.

Unapproved drops for pink eye pulled by Amazon 

Separately, the FDA is warning Amazon about its distribution of seven products marketed as solutions for pink eye, despite being unapproved as a drug.

Ophthalmic drug products intended for administration into the eyes in general pose a greater risk of harm to users because such products bypass some of the body's natural defenses, the FDA stated on Monday in a warning letter to Amazon.

Amazon told CBS MoneyWatch the products have been removed from its website. They include: Similasan Pink Eye Relief, The Goodbye Company Pink Eye, Can-C Eye Drops, Optique 1 Eye Drops, OcluMed Eye Drops, TRP Natural Eyes Floaters Relief and Manzanilla Sophia Chamomile Herbal Eye Drops products. 

—Elizabeth Napolitano contributed to this report.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.